Community Training on Drug-Resistant TB Treatment: Medicines, Side-Effects, Drug-Drug Interactions, and Monitoring Strategies
2 February 2025
6 February 2025, 8:30 – 10:00 AM EDT
Join Treatment Action Group (TAG) for the next in a series of community trainings on drug-resistant TB (DR-TB). Dr. Jennifer Furin will provide a deep dive on the drugs currently being used in regimens to treat DR-TB, with a focus on side effects, drug-drug interactions, and optimal monitoring strategies for people taking these medications as part of their therapy.
Register for the webinar here.
You can access recordings from the previous community training sessions on The Basics of Drug-Resistant TB, Recent Updates to the World Health Organization Drug-Resistant TB Treatment Guidelines, and Updates on Drug-Resistant TB in Children, Pregnant People, and Other Special Populations here.
